Web Analytics
Cổ phiếu VXRT (NASDAQ) | VAXART INC – Phân tích Deepscope
MARKET

Select Market Data Region

VXRT — VAXART INC (Healthcare >> Biotechnology)

VXRT FAQ

What is VXRT's P/E ratio?

VAXART INC (VXRT) currently trades at a P/E ratio of 2.49.

What is VXRT's ROE?

VAXART INC reports a Return on Equity (ROE) of 39.42%.

What is VXRT's dividend yield?

VAXART INC offers a dividend yield of 0.00%.

What is VXRT's Deepscope Quality Score?

Deepscope rates VXRT's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy VXRT?

Deepscope's AI Timing Score for VXRT is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does VXRT belong to?

VAXART INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-09 | FS: 2026-03-31)

VXRT

VAXART INC
USD 0.58
-0.02 (-3.12%) Day Change
2.49
P/E
0.03
D/E
39.4%
ROE
20.6%
ROA
0.00%
Div Yield
-0.04
PEG
USD 0.58
Price
-0.02 (-3.12%)
Day Change
NEWS SCORE: 94

VXRT Chất lượng tổng thể của cố phiếu Không tốt lắm ( Chất lượng = 54) và Thời điểm mua ...(Sign In to See)...

54

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Khá , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng 60%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 94
  Magic Formula Rank by ROA
197
  Magic Formula Rank by ROE
197
  Magic Formula Rank by ROIC
100
GOOD
  Price 0.58
  PBV / Sector
1.59 / 4.71
GOOD
  Earning Per Share 0.14
  PE / Sector
2.49 / 17.58
GREAT
  PEG or PE/Growth / Sector
-0.04 / 0.53
  Average 1M Daily Value
0.13 M
GREAT
  Average 1W Daily Value
0.11 M
GREAT
Yếu tố Kỹ thuật 28%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Sức khỏe tài chính 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Khả năng kiếm lợi nhuận 56%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
14.51 / 468.85
  NPM Average (%) / Sector
-20,407.57 / -1,531.69
  NPM Change Average (%) / Sector
-42.52 / 5,028.65
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
20.60 / 31.69
GOOD
  ROA Average (%) / Sector
-34.14 / -353.18
  ROA Change Average (%) / Sector
-3.49 / 5,214.65
  ROE (%) / Sector
39.42 / 10.58
GREAT
  ROE Average (%) / Sector
-59.14 / 27.64
  ROE Change Average (%) / Sector
5.41 / 2,048.88
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Lợi tức cho nhà đầu tư 4%
X
  Dividend (%) / Sector
N/A / 0.05
  Dividend Average (%) / Sector
N/A / 16.49
  Dividend Change Average (%) / Sector
N/A / 3.68
Chi tiết đăng ký
X
  Analyze Date 2026-06-10 09:43:30
  Symbol VXRT
  Name VAXART INC
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 242.04 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 150.07 / 8,889.42
Tin tức, Dự báo ước tính
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 310 Utah Avenue, South San Francisco, CA, United States, 94080

Phone: 650 550 3500

Website: https://vaxart.com

Employees: 65

Sector: Healthcare >> Biotechnology

Description: Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII; COVID-19 Vaccine, which is in Phase 2b clinical trial for the treatment of SARS-CoV-1, SARS-CoV-2, and Middle East respiratory syndrome coronavirus; Seasonal Influenza vaccine, which is in Phase 2 clinical trial, to treat H1N1 Influenza; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. The company also provides VAAST (Vector-Adjuvant-Antigen Standardized Technology) Platform, a unique modular vaccine platform. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.

ME vs SECTOR Healthcare >> Biotechnology

VXRT (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
VXRT
VXRT
USD 0.58 (-3.12%)
+ Watch + Port Chart